News

A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers

Building on a BC Cancer discovery from decades past, a new combination treatment has shown promise to overcome drug resistance and relapse in people with chronic myeloid leukemia.

Building off the discovery of an enzyme called integrin-linked kinase (ILK) made by BC Cancer distinguished scientist Dr. Shoukat Dedhar 24 years ago, BC Cancer’s Drs. Xiaoyan Jiang and Shoukat Dedhar have made a significant advancement in understanding the role of this enzyme in blood cancers.

More Info about A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers

Congratulations to our Integrative Oncology scholarship and award winners

Several members from BC Cancer – Research’s Integrative Oncology Department were recently recognized with scholarships and awards. Congratulations to Ian Janzen, Tianna Sihota, Rachel Cederberg, and Cariad Knight.

More Info about Congratulations to our Integrative Oncology scholarship and award winners

Congratulations to Andrea (Andie) Buenconsejo on her first publication

Congratulations to Andrea (Andie) Buenconsejo on her first publication titled "Submillimeter diameter rotary-pullback fiber-optic endoscope for narrowband red-green-blue reflectance, optical coherence tomography, and autofluorescence in vivo imaging" published in Journal of Biomedical Optics.

More Info about Congratulations to Andrea (Andie) Buenconsejo on her first publication

Spotlight on oral cancer research expert Dr. Catherine Poh  

Get to know Dr. Dr. Poh, who is leading the way in oral cancer research to provide better treatment outcomes for patients.

More Info about Spotlight on oral cancer research expert Dr. Catherine Poh

Dr. Andrew Minchinton receives CIHR project grant of $573,750 for “Hypoxia-activated DNA Repair Inhibitors to Improve Cancer Therapy”

Congratulations to Dr. Andrew Minchinton for receiving a CIHR project grant of $573,750 for “Hypoxia-activated DNA Repair Inhibitors to Improve Cancer Therapy”.

More Info about Dr. Andrew Minchinton receives CIHR project grant of $573,750 for “Hypoxia-activated DNA Repair Inhibitors to Improve Cancer Therapy”

Congratulations to Dr. Will Lockwood for receiving a BC Lung Association grant for “Defining mechanisms of lineage transformation in lung adenocarcinoma to combat therapy resistance".

A new combination treatment targeting “cancer stem cells” may overcome drug resistance in blood cancers

Congratulations to our Integrative Oncology scholarship and award winners

Congratulations to Andrea (Andie) Buenconsejo on her first publication

Spotlight on oral cancer research expert Dr. Catherine Poh

Dr. Andrew Minchinton receives CIHR project grant of $573,750 for “Hypoxia-activated DNA Repair Inhibitors to Improve Cancer Therapy”

Congratulations to Dr. Will Lockwood for receiving a BC Lung Association grant for “Defining mechanisms of lineage transformation in lung adenocarcinoma to combat therapy resistance".

BC Cancer Research

Office of Research Administration

Cancer Control Research

Genome Sciences Centre

Terry Fox Laboratory

Molecular Oncology

Integrative Oncology

Lymphoid Cancer Research

Clinical Research

Experimental Therapeutics

Deeley Research Centre